Revolution Medicines, Inc. Total Current Assets decreased by 5.2% to $1.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $2.13B to $1.97B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 35.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $661.01M | $623.54M | $589.77M | $534.34M | $483.05M | $675.11M | $660.19M | $922.75M | $922.09M | $824.47M | $1.88B | $1.73B | $1.62B | $1.58B | $2.33B | $2.13B | $2.18B | $1.98B | $2.08B | $1.97B |
| QoQ Change | — | -5.7% | -5.4% | -9.4% | -9.6% | +39.8% | -2.2% | +39.8% | -0.1% | -10.6% | +127.9% | -8.0% | -6.0% | -2.8% | +47.4% | -8.3% | +2.0% | -9.1% | +4.9% | -5.2% |
| YoY Change | — | — | — | — | -26.9% | +8.3% | +11.9% | +72.7% | +90.9% | +22.1% | +184.7% | +87.4% | +76.2% | +91.5% | +23.9% | +23.4% | +34.0% | +25.2% | -10.9% | -7.8% |